JPH02270808A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH02270808A JPH02270808A JP9117789A JP9117789A JPH02270808A JP H02270808 A JPH02270808 A JP H02270808A JP 9117789 A JP9117789 A JP 9117789A JP 9117789 A JP9117789 A JP 9117789A JP H02270808 A JPH02270808 A JP H02270808A
- Authority
- JP
- Japan
- Prior art keywords
- protease
- skin
- modified
- cosmetic
- modified protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 239000004365 Protease Substances 0.000 claims abstract description 88
- 108091005804 Peptidases Proteins 0.000 claims abstract description 87
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 81
- 125000003277 amino group Chemical group 0.000 claims abstract description 13
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 13
- 239000005017 polysaccharide Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 8
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims abstract description 7
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 150000004676 glycans Chemical class 0.000 claims abstract 4
- 230000004048 modification Effects 0.000 claims description 12
- 238000012986 modification Methods 0.000 claims description 12
- 230000007815 allergy Effects 0.000 abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 4
- 239000004373 Pullulan Substances 0.000 abstract description 4
- 229920001218 Pullulan Polymers 0.000 abstract description 4
- 238000002845 discoloration Methods 0.000 abstract description 4
- 235000019423 pullulan Nutrition 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000006210 lotion Substances 0.000 description 24
- 238000003860 storage Methods 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 239000006071 cream Substances 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 206010070835 Skin sensitisation Diseases 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 231100000370 skin sensitisation Toxicity 0.000 description 10
- 239000000344 soap Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 150000004804 polysaccharides Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000008267 milk Substances 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 239000002884 skin cream Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229920002307 Dextran Polymers 0.000 description 5
- 108010003855 mesentericopeptidase Proteins 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000009739 binding Methods 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- -1 punk Substances 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、修飾プロテアーゼを配合してなる化粧料に関
し、詳しくは、プロテアーゼの作用により皮膚或いは毛
髪に滑らかさや艶を付与しうる、保存安定性、皮膚安定
性、実用特性に優れた新規な化粧料に関するものである
。Detailed Description of the Invention [Field of Industrial Application] The present invention relates to cosmetics containing a modified protease, and more specifically, cosmetics that are storage stable and can impart smoothness and luster to the skin or hair through the action of the protease. The present invention relates to a novel cosmetic with excellent properties, skin stability, and practical properties.
従来プロテアーゼ等9加水分解酵素による皮膚の汚れl
成分や老化角質の分解作用を利用した酵素配合の化粧料
が種々提案されている。Conventional skin stains caused by 9 hydrolytic enzymes such as proteases
Various enzyme-containing cosmetics have been proposed that utilize ingredients and the decomposition action of aged keratin.
例えば特開昭58−77808号公報「クリーム組成物
」では、加水分解酵素を乳化物に配合する化粧料が提案
されているが酵素をそのまま水を含む乳化物に配合した
だけでは、酵素が原因となって化粧料が経口により変色
や変臭を生起したり、皮膚刺激やアレルギーを与えたり
して好ましくない。For example, in JP-A-58-77808 ``Cream Composition,'' a cosmetic composition in which a hydrolytic enzyme is blended into an emulsion is proposed, but if the enzyme is simply blended into an emulsion containing water, the enzyme may This is undesirable because cosmetics may cause discoloration and odor when taken orally, and may cause skin irritation or allergies.
また、特開昭63−130415号公報「粉末化粧料」
では、加水分解酵素を配合した粉末化粧料が提案されて
いるが、酵素活性を発現させるため使用時水と混和せね
ばならない為、使用が簡便でなく、酵素が原因となって
皮膚に刺激やアレルギーを与えて好ましくない。Also, JP-A-63-130415 ``Powder cosmetics''
Powdered cosmetics containing hydrolytic enzymes have been proposed, but they are not easy to use because they must be mixed with water to develop the enzyme activity, and the enzymes may cause irritation to the skin. It is undesirable because it causes allergies.
また、このような欠点を改良するため本発明者らは、特
願昭60−82022号公報「乳化型皮膚化粧料」で固
定化加水分解酵素の粉末を配合した乳化型化粧料を提案
しているが、これら化粧料は、使用時ざらざらした感じ
を与え、使用感が好ましくないという欠点を有していた
。In addition, in order to improve such drawbacks, the present inventors proposed an emulsified cosmetic containing powdered immobilized hydrolytic enzyme in Japanese Patent Application No. 82022/1988 entitled "Emulsified Skin Cosmetic". However, these cosmetics have the disadvantage that they give a rough feeling when used, making them unpleasant to use.
本発明者らは、上記従来技術の難点を改良せんとして鋭
意研究した結果、後記特定の修飾酵素を配合して得られ
る化粧品により上記欠点が解決されることを見出し、本
発明を完成した。ずなわら、本発明の目的は、使用簡便
で、皮膚に刺激やアレルギーを与えることがないように
安全性が高く、経口によっても変臭や変色を生起するこ
となく、皮膚に対しては、老化角質を除去して滑らかさ
を付与し、毛髪に対しては、艶と仕上がり効果をイ・]
与する化粧料を提供するにある。As a result of intensive research aimed at improving the drawbacks of the above-mentioned conventional techniques, the present inventors discovered that the above-mentioned drawbacks could be solved by cosmetics obtained by blending specific modified enzymes described below, and completed the present invention. However, the purpose of the present invention is to provide a product that is easy to use, highly safe so as not to cause irritation or allergies to the skin, and which does not cause odor or discoloration even when administered orally, and which is suitable for the skin. Removes aging keratin and gives smoothness, and gives shine and finish to hair.]
Our aim is to provide cosmetics that provide the desired benefits.
本発明は、臭化シアンにより反応活性基を導入した多t
i [とプロテアーゼとを結合させることによって得ら
れ、且つそのプロテアーゼの表面アミノ基の修飾率がT
NBS法で測定して15%以−にである修飾プロテアー
ゼを配合していることを特徴とする化粧料である。The present invention provides multi-t
i[ and the modification rate of the surface amino groups of the protease is T
This cosmetic is characterized by containing 15% or more of a modified protease as measured by the NBS method.
次に本発明の構成を詳細に説明する。Next, the configuration of the present invention will be explained in detail.
本発明に用いる修飾プロテアーゼは、プロテアーゼと、
臭化シアンによって活性化された多糖類とを結合さセて
得られる。The modified protease used in the present invention includes protease,
It is obtained by combining it with a polysaccharide activated by cyanogen bromide.
ここで使用されるプロテアーゼは、例えば、トリプシン
、キモトリプシンなどの動物由来のプロテアーゼ、微生
物由来のプロテアーゼ等が挙げられる。本発明の修飾プ
ロテアーゼはいずれも抗原性や皮膚感作性が抑制されて
おり、また安定性も大きく向上する。しかし、プロテア
ーゼの違いにより相対的に安定性は異なる。安定性の点
からは、動物由来のプロテアーゼと比較すると微生物由
来のプロテアーゼに優れているものが多い。したがって
、好ましくは微生物由来のプロテアーゼ、特に好ましく
はバチルス属由来のプロテアーゼを用い名と好結果が得
られる。Examples of the protease used here include animal-derived proteases such as trypsin and chymotrypsin, microbial-derived proteases, and the like. All of the modified proteases of the present invention have suppressed antigenicity and skin sensitization, and also have greatly improved stability. However, the relative stability varies depending on the protease. In terms of stability, many proteases derived from microorganisms are superior to proteases derived from animals. Therefore, preferably a protease derived from a microorganism, particularly preferably a protease derived from the genus Bacillus, can be used with good results.
また、多IJi [としては、例えばアガロース、グア
ーガム、イヌリン、デンプン、デキストラン、プルラン
、ザンタンガム、カラギーナン、ペクチン、アルギン酸
などの天然多糖類及びその誘導体や、ヒドロキシプロピ
ルセルロース、メチルセルロース、エチルセルロース、
カルボキシメチルセルロースなどが挙げられる。なかで
もデキストラン、プルランは、かなりの高分子量のもの
を用いても溶液粘度が低く、反応操作が容易で、かつ、
得られる修飾プロテアーゼの性能も安定で、均一な好ま
しい結果を与える。In addition, polysaccharides such as agarose, guar gum, inulin, starch, dextran, pullulan, xanthan gum, carrageenan, pectin, alginic acid and other natural polysaccharides and their derivatives, hydroxypropyl cellulose, methyl cellulose, ethyl cellulose,
Examples include carboxymethylcellulose. Among them, dextran and pullulan have a low solution viscosity even when using a substance with a fairly high molecular weight, and the reaction operation is easy, and
The performance of the resulting modified protease is also stable and gives uniform favorable results.
多$7!tfiの分子量は、特に著しく小さいものでな
ければ、修飾プロテアーゼの安定性は良好な結果を与え
るが、抗原性などはかなり分子量の影響を受けるため、
その平均分子量は10. OO0以上、特に好ましくは
40.000以上のものを用いると好結果が得られる。More than $7! As long as the molecular weight of TFI is not extremely small, the stability of the modified protease will give good results, but antigenicity etc. are significantly affected by the molecular weight.
Its average molecular weight is 10. Good results can be obtained by using a value of OO0 or more, particularly preferably 40,000 or more.
本発明に用いる修飾プロテアーゼを得るには、まず臭化
シアンにより多糖類を活性化し、この活性化体とプロテ
アーゼを一般に用いられる方法に従って結合させればよ
い。In order to obtain the modified protease used in the present invention, a polysaccharide may first be activated with cyanogen bromide, and the activated form and protease may be combined according to a commonly used method.
この様にして得られた修飾プロテアーゼ中のプロテアー
ゼの表面アミノ基の修飾率は、用いる多IJN [の種
類、混合比、反応条件によって異なるが、得られた修飾
プロテアーゼの安全性、安定性の各性能を確保するため
には、この修飾率を′I” N 13 S法で測定して
15%以上とすることが必要である。The degree of modification of the surface amino groups of the protease in the modified protease obtained in this way varies depending on the type of multi-IJN used, the mixing ratio, and the reaction conditions, but the degree of modification depends on the safety and stability of the obtained modified protease. In order to ensure performance, it is necessary that this modification rate be 15% or more as measured by the 'I'' N 13 S method.
更に、臭化シアンにより活性化された多$M類とプロテ
アーゼとの結合反応において、活性化された多糖類は、
重量比にしてプロテアーゼの3倍以上を用いることが必
要である。3倍未満では、抗原性、皮膚感作性の抑制が
十分な修飾プ、ロチアーゼを得ることができず、良好な
結果が得られない。Furthermore, in the binding reaction between poly$Ms and protease activated by cyanogen bromide, the activated polysaccharide is
It is necessary to use at least three times the weight of protease. If the amount is less than 3 times, it will not be possible to obtain a modified prothiase with sufficient suppression of antigenicity and skin sensitization, and good results will not be obtained.
また、過剰に多糖類を加えても得られる修飾プロテアー
ゼの性能は飽和するため、その使用量は20倍以下にす
ることが好ましい。Furthermore, even if an excessive amount of polysaccharide is added, the performance of the resulting modified protease will be saturated, so the amount used is preferably 20 times or less.
また、上記製造法において、多糖類の活性化反応は、p
Hl0〜11.25℃以下、また、結合反応は、p H
8,5〜9.5.5°C以下で行うことが好ましい。In addition, in the above production method, the activation reaction of the polysaccharide is p
Hl0~11.25℃ or less, and the binding reaction is performed at pH
It is preferable to carry out the reaction at a temperature of 8.5 to 9.5.5°C or lower.
また、多糖類とプロテアーゼの結合反応に於ける酵素濃
度も、得られた修飾プロテアーゼの各性質に影響を与え
る。酵素濃度が過度に大きいと、抗原性や皮膚感作性の
抑制が完全でなくなる場合もあるため、酵素濃度は1重
量%以下とすることが好ましい。Furthermore, the enzyme concentration in the binding reaction between polysaccharide and protease also influences the properties of the obtained modified protease. If the enzyme concentration is too high, antigenicity and skin sensitization may not be completely suppressed, so the enzyme concentration is preferably 1% by weight or less.
6一
プロテアーゼと活性化体との結合反応の後、多糖類の余
剰活性基に対しては、リジン、グリシン、アミノエタノ
ール等を添加し、後処理を行うことにより安定な品質を
得ることができる。また、得られた修飾プロテアーゼは
、限外濾過、ゲル口過液体クロマト法などにより精製す
ることができる。After the binding reaction between the 6-protease and the activated form, stable quality can be obtained by adding lysine, glycine, aminoethanol, etc. to the excess active groups of the polysaccharide and performing post-treatment. . Further, the obtained modified protease can be purified by ultrafiltration, gel filtration liquid chromatography, or the like.
本発明において修飾プロテアーゼの配合量は化粧料全量
を100重量部として、好ましくは0、0001〜5重
量部である。0.0001重量部より少ないと化粧料に
おけるプロテアーゼの働きが十分でないことがある。又
、5重量部を超えても配合量に見合う効果はあまり期待
できない。In the present invention, the amount of modified protease blended is preferably 0,0001 to 5 parts by weight, based on 100 parts by weight of the total amount of the cosmetic. If the amount is less than 0.0001 part by weight, the protease in the cosmetic may not function sufficiently. Furthermore, even if the amount exceeds 5 parts by weight, it is not expected to produce much effect commensurate with the amount incorporated.
本発明の化粧料には、保湿剤、水溶性高分子、界面活性
剤、水、油、ワックス、香料、着色剤、防腐剤、酸化防
止剤、殺菌剤、アミノ酸、ビタミン、ホルモン、紫外線
吸収剤等通常化粧品に用いられる成分を適宜配合する事
ができる。The cosmetics of the present invention include humectants, water-soluble polymers, surfactants, water, oils, waxes, fragrances, colorants, preservatives, antioxidants, bactericides, amino acids, vitamins, hormones, and ultraviolet absorbers. Ingredients commonly used in cosmetics can be appropriately blended.
本発明の化粧料は、スキンクリーム、スキンミルク、ク
レンジンクリリーム、クレンジングミルク、コールドク
リーム、クリームソーブ、メイクアップベース、スキン
ローション、ミルキイローション、パンク、カラミンロ
ーション、Tゾーンエツセンス、ハンドクリーム、工・
ノセシスノくうダー、ホワイトニングパウダー、パウダ
ーソープ、固型石鹸、透明石鹸、リップクリーム、口紅
、栄養エツセンス、クリーミイファンデーション、フェ
ースパウダー、パウダーアイシャドウ、ノぐウダーファ
ンデーション、ネイルリムーバー、ヘアートニック、ヘ
アーリキ・ノド、ヘアークリーム、ヘアートリートメン
ト、スカルプトリートメント、シャンプー、リンス、ヘ
アースプレー、サンオイル、サンスクリーン、シェービ
ングフオーム、シェービングクリーム、ヘビーオイル等
に適用される。The cosmetics of the present invention include skin cream, skin milk, cleansing cream, cleansing milk, cold cream, cream sorb, makeup base, skin lotion, milky lotion, punk, calamine lotion, T zone essence, hand cream,・
Nosesis powder, whitening powder, powder soap, bar soap, transparent soap, lip balm, lipstick, nutritional essence, creamy foundation, face powder, powder eye shadow, powder foundation, nail remover, hair tonic, hair riki nodo, Applicable to hair cream, hair treatment, scalp treatment, shampoo, conditioner, hair spray, sun oil, sunscreen, shaving foam, shaving cream, heavy oil, etc.
以下、実施例を挙げて本発明を具体的に説明する。 The present invention will be specifically described below with reference to Examples.
なお、本発明において、プロテアーゼの表面アミノ基修
飾率、熱安定性、抗原性、保存安定性。In addition, in the present invention, the surface amino group modification rate, thermal stability, antigenicity, and storage stability of protease.
皮膚感作性、実用特性はつぎのようにして行った。Skin sensitization and practical properties were evaluated as follows.
(Ij プロテアーゼの表面アミノ基修飾率ハインズ
(It a y n e s )らの方法(llayn
es、 R,eLal。(Surface amino group modification rate of Ij protease by the method of Itaynes et al.
es, R, eLal.
Biochemistry、 6. 541 (1
967) )により、トリニトロヘンゼンスルホン酸(
TNBS)の反応量として修飾プロテアーゼ表面の未反
応のアミノ基量を測定し、未修飾体の表面アミノ基量と
の比から表面アミノ基の修飾率を算出した。Biochemistry, 6. 541 (1
967) ) to trinitrohenzenesulfonic acid (
The amount of unreacted amino groups on the surface of the modified protease was measured as the reaction amount of TNBS), and the modification rate of the surface amino groups was calculated from the ratio to the amount of surface amino groups of the unmodified product.
(2) 熱安定性
試料を60℃で6時間インキュヘーションを行った後、
酵素活性を測定し下記の式より求めた。(2) After incubating the thermally stable sample at 60°C for 6 hours,
Enzyme activity was measured and calculated using the following formula.
熱安定性(%)−
(3) 抗原性
試料0.4 m lに、あらかじめ別に用意した抗血清
0.4 m l)を加え、30°Cで2時間インキュヘ
ーションを行った。生成した沈澱を遠心分離により分取
し、75mMリン酸緩衝液(pH7,8)1mAで3回
洗浄した後0.lN NaOH3mj!を加えてこれ
を溶解し、285nmに於ける吸光度を測定した。Thermal stability (%) - (3) 0.4 ml of antiserum prepared separately in advance was added to 0.4 ml of the antigenic sample, and incubation was performed at 30°C for 2 hours. The generated precipitate was collected by centrifugation, washed three times with 1 mA of 75 mM phosphate buffer (pH 7, 8), and then washed with 0.0 mA of 75 mM phosphate buffer (pH 7, 8). lN NaOH3mj! was added to dissolve it, and the absorbance at 285 nm was measured.
抗原性の判定は下記基準に従った。Antigenicity was determined according to the following criteria.
(4) 保存安定性
試料を密封し、45“Cの恒温槽に遮光して3ケ月間放
置した後、色と匂いの変化の有無を観察した。(4) Storage stability The samples were sealed and left in a constant temperature bath at 45"C for 3 months, protected from light, and then observed for changes in color and odor.
(5) 皮膚感作性
マキシミゼーション(Maximization)法(
Bertil。(5) Skin sensitization maximization method (
Bertil.
M and Albert、 M、 K、+ J、 I
nvest、 Derm、、 52(3)、268
(1969))に基づき、皮膚感作性試験を行った。M and Albert, M, K, + J, I
nvest, Derm, 52(3), 268
(1969)), a skin sensitization test was conducted.
誘導及び惹起とも試料をそのまま用いた。皮膚感作性の
程度を下記に示す平均評価点から求めた。The samples were used as they were for both induction and challenge. The degree of skin sensitization was determined from the average score shown below.
(6) 実用特性
専門検査員20名が101回、3日間連続して実用テス
トを行ない、下記試験項目のアンケートに回答した。(6) 20 practical property specialist inspectors conducted practical tests 101 times over three consecutive days and answered the questionnaire regarding the following test items.
■使用簡便性: 使用簡便であると答えた人数。■Easy to use: Number of people who answered that it was easy to use.
■使用時のざらつき: 使用時ざらつきを感じたと答えた人数。■Roughness during use: Number of people who said they felt rough when using it.
■使用後の刺激感: 使用後、皮膚(頭皮)に刺激を感じたと答えた人数。■Irritation after use: Number of people who said they felt irritation on their skin (scalp) after using the survey.
■使用後のなめらかさ:
使用後、皮膚(毛髪)がなめらかになったと答えた人数
。■Smoothness after use: Number of people who said their skin (hair) became smoother after use.
■使用後のつや: 使用後、皮膚(毛髪)につやがでたと答えた人数。■Gloss after use: Number of people who said their skin (hair) became shiny after using it.
実施例1 スキンローション 下記処方のスキンローションを常法によって調製した。Example 1 Skin lotion A skin lotion with the following formulation was prepared by a conventional method.
得られたスキンローションの特性を第1表に示す。第1
表から明らかな如く本発明のスキンローションは熱安定
性、実用特性、保存安定性に優れ、抗原性、皮膚感作性
の低いものであった。The properties of the obtained skin lotion are shown in Table 1. 1st
As is clear from the table, the skin lotion of the present invention had excellent thermal stability, practical properties, and storage stability, and had low antigenicity and skin sensitization.
(スキンローションの処方)
(修飾プロテアーゼの調製)
デキストラン(平均分子量6〜9X10’)1.0gを
20m7!の水にン容解した。これに1NN a OH
を加えp H10,4とした。臭化シアン259mgを
3mlの水にン容解し、この?容液を室温にてデキスト
ラン水溶液に徐々に加え、その際、lNNaOHを同時
に加えてp Hを10前後に保った。この操作を約15
分で終えた後、約10分間撹拌し、4%N a HCO
水溶液を加えてp I+9とした。次に、この活性化し
たデキストラン溶液にバチルス・リケニホルミス菌(B
aciluslicheniformis)由来のプロ
テアーゼ〈ノボ社製、商品名エスペラーゼ〉 (以下エ
スペラーゼと記す)100mgを加え、4℃にて24時
間反応せしめた。この反応液にグリシン4.0 m g
を加え、2時間処理した後、溶液を限外濾過し、精製濃
縮した後、凍結転属した。(Formulation of skin lotion) (Preparation of modified protease) 1.0g of dextran (average molecular weight 6-9X10') in 20m7! It was dissolved in water. 1NN aOH to this
was added to adjust the pH to 10.4. Dissolve 259 mg of cyanogen bromide in 3 ml of water and add this solution. The solution was gradually added to the dextran aqueous solution at room temperature, and at the same time, 1N NaOH was added to maintain the pH at around 10. Do this operation for about 15
After a minute, stir for about 10 minutes and add 4% NaHCO.
Aqueous solution was added to give p I+9. Next, this activated dextran solution was added to Bacillus licheniformis (B.
100 mg of protease derived from A. acilus licheniformis (manufactured by Novo, trade name: Esperase) (hereinafter referred to as Esperase) was added, and the mixture was allowed to react at 4°C for 24 hours. Add 4.0 mg of glycine to this reaction solution.
After treatment for 2 hours, the solution was ultrafiltered, purified and concentrated, and then frozen and transferred.
得られた修飾プロテアーゼの表面アミノ基修飾率は17
%、酵素活性保持率は27%であった。The surface amino group modification rate of the obtained modified protease was 17
%, and the enzyme activity retention rate was 27%.
実施例2 スキンローション
実施例1の修飾プロテアーゼの代わりに、下記の如く調
製した修飾プロテアーゼを用いる他は実施例と同様にし
て本発明のスキンローションを得た。Example 2 Skin Lotion A skin lotion of the present invention was obtained in the same manner as in Example except that a modified protease prepared as described below was used instead of the modified protease of Example 1.
その特性を第1表に示す。第1表から明らがな如く、本
発明のスキンローションは熱安定性、実用特性、保存安
定性に優れ、抗原性、皮膚感作性の低いものであった。Its characteristics are shown in Table 1. As is clear from Table 1, the skin lotion of the present invention had excellent thermal stability, practical properties, and storage stability, and had low antigenicity and skin sensitization.
(修飾プロテアーゼの調製)
実施例1の(修飾プロテアーゼの調製)の所で用いたデ
キストラン(平均分子量6〜9X10’)の代わりにプ
ルラン(平均分子量50.000)を用い、かつプロテ
アーゼとしてエスペラーゼの代わりにビオプラーゼ(ナ
ガセ生化学社製)を用いる他は実施例1の(修飾プロテ
アーゼの調製)と同様にして、修飾プロテアーゼを調製
した。(Preparation of modified protease) Pullulan (average molecular weight 50.000) was used instead of dextran (average molecular weight 6 to 9×10') used in Example 1 (preparation of modified protease), and esperase was used as protease. A modified protease was prepared in the same manner as in Example 1 (preparation of modified protease), except that Bioplase (manufactured by Nagase Biochemical Co., Ltd.) was used.
得られた修飾プロテアーゼの表面アミノ基修紳率は22
%、活性保持率は33%であった。The surface amino group modification rate of the obtained modified protease was 22
%, and the activity retention rate was 33%.
実施例3 スキンローション
実施例1の修飾プロテアーゼの代わりに、下記の如く調
製した修飾プロテアーゼを用いる他は実施例1と同様に
して本発明のスキンローションを得た。Example 3 Skin Lotion A skin lotion of the present invention was obtained in the same manner as in Example 1, except that a modified protease prepared as described below was used instead of the modified protease in Example 1.
その特性を第1表に示す。第1表から明らかな如く、本
発明のスキンローションは熱安定性、実−14=
用特性2保存安定性に優れ、抗原性、感作性の低いもの
であった。Its characteristics are shown in Table 1. As is clear from Table 1, the skin lotion of the present invention had excellent thermal stability and storage stability, and had low antigenicity and sensitization.
(修飾プロテアーゼの調製)
実施例1の(修飾プロテアーゼの調製)の所で用いたデ
キストラン(分子量6〜9X10’)代わりにメチルセ
ルロース(和光純薬社製25CP)を用いる他は実施例
1の(修飾プロテアーゼの調製)と同様にして、修飾プ
ロテアーゼを調製した。(Preparation of modified protease) The procedure of Example 1 (modified Modified protease was prepared in the same manner as in (Preparation of protease).
得られた修飾プロテアーゼの表面アミノ基修飾率は20
%、′活性保持率は30%であった。The surface amino group modification rate of the obtained modified protease was 20
%, 'activity retention rate was 30%.
実施例4 スキンローション
実施例Iの修飾プロテアーゼの代わりに、下記の如く調
製した修飾プロテアーゼを用いる他は実施例1と同様に
して本発明のスキンローションを得た。Example 4 Skin lotion A skin lotion of the present invention was obtained in the same manner as in Example 1, except that a modified protease prepared as described below was used instead of the modified protease of Example I.
その特性を第1表に示す。第1表から明らかな如く、本
発明のスキンローションは熱安定性、実用特性、保存安
定性に優れ、抗原性、感作性の低いものであった。Its characteristics are shown in Table 1. As is clear from Table 1, the skin lotion of the present invention had excellent thermal stability, practical properties, and storage stability, and had low antigenicity and sensitization.
(修飾プロテアーゼの調製)
わりにイヌリン(平均分子量50,000)を用い、か
つプロテアーゼとしてエスペラーゼの代わりにキモトリ
プシン(シグマ社製)を用いる他は実施例1の(修飾プ
ロテアーゼの調製)と同様にして、修飾プロテアーゼを
調製した。(Preparation of modified protease) In the same manner as in Example 1 (preparation of modified protease) except that inulin (average molecular weight 50,000) was used instead and chymotrypsin (manufactured by Sigma) was used instead of esperase as protease. A modified protease was prepared.
得られた修飾プロテアーゼの表面アミノ基修飾率は18
%、活性保持率は27%であった。The surface amino group modification rate of the obtained modified protease was 18
%, and the activity retention rate was 27%.
比較例1 スキンローション
実施例1の修飾プロテアーゼの代わりに、未修飾のプロ
テアーゼを用いる外は実施例1と同様にして比較のスキ
ンローションを調製した。Comparative Example 1 Skin Lotion A comparative skin lotion was prepared in the same manner as in Example 1, except that unmodified protease was used instead of the modified protease in Skin Lotion Example 1.
その特°性を第1表に示す。第1表から明らかな如く、
修飾していないプロテアーゼを配合した比較のスキンロ
ーションは熱安定性が著しく悪く、抗原性、皮膚感作性
が認められ、使用時刺激を惑し、保存安定性の悪いもの
であった。Its properties are shown in Table 1. As is clear from Table 1,
A comparative skin lotion containing unmodified protease had extremely poor thermal stability, antigenicity and skin sensitization, caused irritation during use, and had poor storage stability.
比較例2 スキンローション
実施例1の修飾プロテアーゼの代わりに、下記の如く調
製した固定化プロテアーゼを用いる他は実施例1と同様
にして比較のスキンローションを調製した。Comparative Example 2 Skin Lotion A comparative skin lotion was prepared in the same manner as in Example 1, except that an immobilized protease prepared as described below was used instead of the modified protease in Skin Lotion Example 1.
その特性を第1表に示す。Its characteristics are shown in Table 1.
第1表から明らかな如く、固定化プロテアーゼを用いた
比較のスキンローションは使用時ざらついたりして、好
ましいものではなかった。As is clear from Table 1, the comparative skin lotion using immobilized protease felt rough upon use and was not desirable.
(固定化プロテアーゼの調製)
塩化カルシウム20重量部を水20重量部に熔解し、こ
れにメタノール80重量部を混合したのち、ナイロン粉
末(平均粒径6〜lOμm)を5重量部を加え分散させ
、50℃で30分間撹拌した。これを回収し、水洗後3
.5M塩酸100重量部中に浸漬し45℃で50分間撹
拌した。水洗後、10%グルタルアルデヒドを含む0.
1 Mホウ酸ナトリウム緩衝液(pH8,5)50重量
部に浸漬し、引き続き同緩衝液で洗浄した。この処理粉
末を、エスペラーゼを1重量部含有する0、 05 M
リン酸すl・リウム緩衝液(p )−17,’ 5)
50重量部の中に添加し、10°Cで5時間反応した
後、水洗し担体結合型の固定化プロテアーゼ粉末を得た
。(Preparation of immobilized protease) 20 parts by weight of calcium chloride was dissolved in 20 parts by weight of water, 80 parts by weight of methanol was mixed therewith, and 5 parts by weight of nylon powder (average particle size 6 to 10 μm) was added and dispersed. , and stirred at 50°C for 30 minutes. After collecting this and washing with water,
.. It was immersed in 100 parts by weight of 5M hydrochloric acid and stirred at 45°C for 50 minutes. After washing with water, 0.00ml containing 10% glutaraldehyde.
It was immersed in 50 parts by weight of 1 M sodium borate buffer (pH 8.5) and then washed with the same buffer. This treated powder was mixed with 0.05 M containing 1 part by weight of esperase.
Soluium phosphate buffer (p)-17,' 5)
The mixture was added to 50 parts by weight, reacted at 10°C for 5 hours, and washed with water to obtain carrier-bound immobilized protease powder.
実施例5 スキンクリーム
実施例1で調製した修飾プロテアーゼを用いて下記処方
のスキンクリームを調製した。Example 5 Skin Cream Using the modified protease prepared in Example 1, a skin cream with the following formulation was prepared.
(スキンクリームの調製法)
油相成分を80℃で均一に加熱溶解し、これに同じく8
0℃で均一に加熱溶解した水相成分を加え、撹拌しなが
ら冷却し、40℃で修飾プロテアーゼを加え、30℃ま
で冷却して本発明のスキン(スキンクリームの処方)
得られたスキンクリームの実用特性、保存安定性を第2
表に示す。第2表から明らかな如く本発明のスキンクリ
ームの実用特性、保存安定性は優れたものであった。(Preparation method for skin cream) The oil phase components were uniformly heated and dissolved at 80°C, and
Add the aqueous phase components uniformly heated and dissolved at 0°C, cool while stirring, add modified protease at 40°C, and cool to 30°C to obtain the skin of the present invention (skin cream formulation). Practical characteristics and storage stability are the second priority.
Shown in the table. As is clear from Table 2, the skin cream of the present invention had excellent practical properties and storage stability.
実施例6 ヘヤークリーム
実施例2で調製した修飾プロテアーゼを用いて下記処方
のヘヤークリームを調製した。Example 6 Hair Cream Using the modified protease prepared in Example 2, a hair cream having the following formulation was prepared.
(ヘヤークリームの調製法)
油相成分を80°Cで均一に加熱熔解し、これに同じく
80℃で均一に加熱溶解した水相成分を加え、撹拌しな
がら冷却し、40℃で修飾プロテアーゼを加え、30℃
まで冷却して本発明のへヤー(ヘヤークリームの処方)
得られたヘヤークリームの実用特性、保存安定性を第2
表に示す。第2表から明らかな如く、本発明のへヤーク
リームの実用特性、保存安定性は優れたものであった。(Preparation method for hair cream) The oil phase component was uniformly heated and melted at 80°C, the aqueous phase component that was also uniformly heated and dissolved at 80°C was added, cooled with stirring, and the modified protease was added at 40°C. In addition, 30℃
The hair cream of the present invention (formulation of hair cream) was cooled to
Shown in the table. As is clear from Table 2, the hair cream of the present invention had excellent practical properties and storage stability.
実施例7 クレンジングミルク
実施例3で調製した修飾プロテアーゼを用いて下記処方
のクレンジングミルクを調製した。Example 7 Cleansing Milk Using the modified protease prepared in Example 3, a cleansing milk with the following formulation was prepared.
(クレンジングミルクの調製法)
油相成分を80℃で均一に加熱溶解し、これに同じく8
0℃で均一に加熱溶解した水相成分を加え、撹拌しなが
ら冷却し、40℃で修飾プロテアーゼを加え、30℃ま
で冷却して本発明のクレン(クレンジングミルクの処方
)
得られたクレンジングミルクの実用特性、保存安定性を
第2表に示す。第2表から明らかな如く、本発明のクレ
ンジングミルクの実用特性、保存安定性は優れたもので
あった。(Preparation method for cleansing milk) Heat and dissolve the oil phase components uniformly at 80°C, and then
Add the aqueous phase components uniformly heated and dissolved at 0°C, cool while stirring, add modified protease at 40°C, and cool to 30°C to prepare the cleansing milk of the present invention (prescription of cleansing milk). Practical properties and storage stability are shown in Table 2. As is clear from Table 2, the cleansing milk of the present invention had excellent practical properties and storage stability.
実施例8 クリームソープ
実施例4で調製した修飾プロテアーゼを用いて下記処方
のクリームソープを調製した。Example 8 Cream Soap Using the modified protease prepared in Example 4, a cream soap having the following formulation was prepared.
(クリームソープの調製法)
水相成分を80°Cで1時間均一に加熱溶解した後、撹
拌しながら冷却し、40℃で修飾プロテアーゼを加え3
0℃まで冷却し、40℃で修飾プロテアーゼを加え30
℃まで冷却してクリームソー(クリームソープの処方)
得られたクリームソープの実用特性、保存安定性を第2
表に示す。第2表から明らかな如く、本発明のクリーム
ソープの実用特性、保存安定性は優れたものであった。(Preparation method for cream soap) After uniformly heating and dissolving the aqueous phase components at 80°C for 1 hour, cooling while stirring, adding modified protease at 40°C.
Cool to 0℃ and add modified protease at 40℃ for 30 minutes.
Cool to ℃ and cream soap (cream soap formulation) The practical properties and storage stability of the obtained cream soap
Shown in the table. As is clear from Table 2, the cream soap of the present invention had excellent practical properties and storage stability.
実施例9 パウダーファンデーション
実施例1で調製した修飾プロテアーゼを用い下記処方の
原料を均一に撹拌混合してパウダーファンデーションを
得た。Example 9 Powder Foundation Using the modified protease prepared in Example 1, raw materials of the following formulation were uniformly stirred and mixed to obtain a powder foundation.
(パウダーファンデーションの処方) 得られたパウダーファンデーションの実用特性。(Powder foundation prescription) Practical properties of the obtained powder foundation.
保存安定性を第2表に示す。第2表から明らかな如<、
本発明のパウダーファンデーションの実用第1表
〔発明の効果〕
上記の如く、本発明の化粧料は、使用簡便で、皮膚に刺
激やアレルギーを与えることなく、保存によっても変臭
や変色を生起することなく、皮膚に対しては、老化角質
を除去して滑らかさを付与し、その作用・効果は顕著で
あった。Storage stability is shown in Table 2. As is clear from Table 2,
Practical use of the powder foundation of the present invention Table 1 [Effects of the invention] As described above, the cosmetic of the present invention is easy to use, does not cause irritation or allergies to the skin, and does not cause odor or discoloration even when stored. It removed aged keratin and imparted smoothness to the skin, and its action and effects were remarkable.
Claims (1)
アーゼとを結合させることによって得られ、且つそのプ
ロテアーゼの表面アミノ基の修飾率がTNBS法で測定
して15%以上である修飾プロテアーゼを配合している
ことを特徴とする化粧料。A modified protease obtained by combining a polysaccharide into which a reactive group has been introduced with cyanogen bromide and a protease, and in which the modification rate of surface amino groups of the protease is 15% or more as measured by the TNBS method. Cosmetics characterized by:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9117789A JP2854599B2 (en) | 1989-04-11 | 1989-04-11 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9117789A JP2854599B2 (en) | 1989-04-11 | 1989-04-11 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02270808A true JPH02270808A (en) | 1990-11-05 |
JP2854599B2 JP2854599B2 (en) | 1999-02-03 |
Family
ID=14019181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9117789A Expired - Fee Related JP2854599B2 (en) | 1989-04-11 | 1989-04-11 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2854599B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0940544A (en) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | Stable composition containing enzyme |
JPH0940543A (en) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | Stable composition containing water-oversensitive make-up and/or dermatological activator |
-
1989
- 1989-04-11 JP JP9117789A patent/JP2854599B2/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0940544A (en) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | Stable composition containing enzyme |
JPH0940543A (en) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | Stable composition containing water-oversensitive make-up and/or dermatological activator |
Also Published As
Publication number | Publication date |
---|---|
JP2854599B2 (en) | 1999-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5230891A (en) | Modified protease, method of producing the same and cosmetic products containing the modified protease | |
KR100613554B1 (en) | Cosmetics | |
US5133968A (en) | Modified protease, method of producing the same and cosmetic products containing the modified protease | |
US7456147B2 (en) | Controlled release of active agents utilizing repeat sequence protein polymers | |
JP2505198B2 (en) | Personal care products containing bioemulsifiers | |
WO2008066193A1 (en) | Cosmetic composition | |
EP0139468B1 (en) | Hair treatment composition | |
JPH0446112A (en) | Trichogen | |
EP0471125B1 (en) | Modified protease, method of producing the same and cosmetic compositions containing the modified protease | |
JP2008110927A (en) | Cosmetic containing royal jelly protein hydrolyzate | |
JP3513872B2 (en) | External preparation for skin | |
JPS6368514A (en) | Cosmetic containing vegetable polypeptide derivative | |
JPH07274914A (en) | Extraction of adlay extract, adlay extract obtained by the extraction and skin-improving article containing the adlay extract | |
JP2854599B2 (en) | Cosmetics | |
JP2546807B2 (en) | Cosmetics | |
JP2953529B2 (en) | New cosmetics | |
JP2854598B2 (en) | Cosmetics | |
JP3505003B2 (en) | External preparation | |
RU2299725C1 (en) | Cosmetic agent for skin care | |
JPH0426604A (en) | Cosmetic and dermatic drug for external use | |
JP2746691B2 (en) | Method for producing surfactant and cosmetics containing the same | |
JPH0477725B2 (en) | ||
JPH0753347A (en) | Skin cosmetic | |
JPH0383908A (en) | Skin cosmetic | |
JPH10251120A (en) | Collagen composition and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |